Protein Expression and Purification

Papers
(The H4-Index of Protein Expression and Purification is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Purification and characterization of a novel extracellular, alkaline, thermoactive, and detergent-compatible lipase from Aeromonas caviae LipT51 for application in detergent industry31
Expression of SARS-CoV-2 surface glycoprotein fragment 319–640 in E. coli, and its refolding and purification30
Linkers: A synergistic way for the synthesis of chimeric proteins27
Yeast-expressed recombinant SARS-CoV-2 receptor binding domain RBD203-N1 as a COVID-19 protein vaccine candidate26
Improved production of SARS-CoV-2 spike receptor-binding domain (RBD) for serology assays24
Expression and purification of recombinant SARS-CoV-2 nucleocapsid protein in inclusion bodies and its application in serological detection20
Recombinant expression and surface display of a zearalenone lactonohydrolase from Trichoderma aggressivum in Escherichia coli18
Stability and cytotoxicity of DPPH inhibitory peptides derived from biodegradation of chicken feather18
A review of alternative promoters for optimal recombinant protein expression in baculovirus-infected insect cells17
Large scale production of synthetic spider silk proteins in Escherichia coli16
Medium optimization for high yield production of human serum albumin in Pichia pastoris and its efficient purification16
Purification and characterization of a cold-adapted κ-carrageenase from Pseudoalteromonas sp. ZDY315
Optimal secretion of thermostable Beta-glucosidase in Bacillus subtilis by signal peptide optimization15
Production of an invertebrate lysozyme of Scylla paramamosain in E.coli and evaluation of its antibacterial, antioxidant and anti-inflammatory effects14
Expression and purification of S5196-272 and S6200-317 proteins from Tilapia Lake Virus (TiLV) and their potential use as vaccines14
Reconstitution and functional characterization of SARS-CoV-2 proofreading complex14
0.089385986328125